Search
Search Results
##search.searchResults.foundPlural##
-
THE TRAGEDY CAUSED BY FAKE ANTIMALARIAL DRUGS
2841PDF: 1105HTML: 1957 -
PROPHYLAXIS OF MALARIA
3084PDF: 1067HTML: 17946Figures SChwartz: 185 -
-
Tuberculosis after gastrectomy, plasmatic concentration of antitubercular drugs
1638PDF: 827HTML: 837tile page: 178Table 1: 186 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1702PDF: 669HTML: 2442 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3408PDF: 1362HTML: 6343 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1540PDF: 1780Suppl. Files: 179HTML: 91 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5550PDF: 1559HTML: 1659Untitled: 253 -
Severe Acute Hepatitis B Treated with Entecavir
1649PDF: 865HTML: 2536Figure: 190Title page: 188disclosure: 114 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1305PDF: 545HTML: 23130 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
880PDF: 496HTML: 1310 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1147PDF: 818HTML: 177 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2757PDF: 978HTML: 627 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
6242PDF: 3428HTML: 9058Figure Malaria Ricci: 253 -
-
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1193PDF: 561HTML: 1704Figures: 186Fifures Sanz: 194tables Sanz: 200Untitled: 191 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3283PDF: 1894HTML: 3687 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3379PDF: 1279HTML: 2363 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1761PDF: 1306HTML: 577 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2323PDF: 1235HTML: 3893 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
1013PDF: 585HTML: 2222Cover Letter: 212 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2986PDF: 1047HTML: 987 -
Stroke in a patient with tuberculous meningitis and HIV infection
1726PDF: 843HTML: 1799figure 1: 182 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
844PDF: 560HTML: 4029 -
ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19
1946PDF: 750HTML: 243 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4053PDF: 1086HTML: 3895Untitled: 187Cneo. Fig.1: 122Untitled: 118Untitled: 144Untitled: 150 -
Spontaneous rupture of malarial spleen: report of two cases
854PDF: 420HTML: 2887jdoe, cover letter.doc: 193 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2054PDF: 768HTML: 718Table1: patient's characteristics: 170Table 2: profile of each patient: 193 -







